0001593968-22-001520.txt : 20221012 0001593968-22-001520.hdr.sgml : 20221012 20221012215948 ACCESSION NUMBER: 0001593968-22-001520 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220701 FILED AS OF DATE: 20221012 DATE AS OF CHANGE: 20221012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yeh Wen-Chen CENTRAL INDEX KEY: 0001873360 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 221307991 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Surrozen, Inc./DE CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 981556622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-475-2820 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Consonance-HFW Acquisition Corp. DATE OF NAME CHANGE: 20200915 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-07-01 0001824893 Surrozen, Inc./DE SRZN 0001873360 Yeh Wen-Chen C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080 false true false false Chief Scientific Officer Option (right to buy) 10.77 2022-10-10 4 D false 29567 D 2021-02-01 2031-02-22 Common Stock 29567 0 D Option (right to buy) 10.77 2022-10-10 4 D false 5562 D 2021-02-01 2031-02-22 Common Stock 5562 0 D Option (right to buy) 3.15 2022-07-01 4 A false 500 0 A 2022-07-21 2032-07-01 Common Stock 500 500 D Option (right to buy) 2.16 2022-10-10 4 A false 5562 A 2021-02-01 2031-02-22 Common Stock 5562 5562 D Option (right to buy) 2.16 2022-10-10 4 A false 29567 A 2021-02-01 2031-02-22 Common Stock 29567 29567 D The reporting person agreed to cancellation of an option granted to him on February 23, 2021, in exchange for a new option having a lower exercise price. The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date. The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 7/21/2022, subject to the reporting person's continued employment through the applicable vesting date. /s/Sheela Mohan-Peterson, Attorney-in-Fact for Wen-Chen Yeh 2022-10-12